
Taxeleon 300mg Injection
Marketer
Neon Laboratories Ltd
Salt Composition
Paclitaxel (300mg)
Overview Taxeleon 300mg Injection
Oncaspar 300mg injection is a cytotoxic agent indicated in the management of breast, pancreatic, and non-small cell lung cancers. Administration is exclusively intravenous, performed by a healthcare professional. Dosage and frequency are determined individually by your physician, based on your specific condition and may be adjusted. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse events. Therapeutic effects may not be immediately apparent, potentially taking weeks or months; discontinuation should only occur under medical supervision. Common side effects include nausea, emesis, and asthenia. Serious adverse reactions such as peripheral edema, alopecia, and weight increase are also possible. Concomitant medications may mitigate some side effects; however, immediately report any unusual bleeding, sore throat, oral ulcers, or pyrexia. This drug can cause myelosuppression, increasing infection risk. Regular hematological and hepatic function monitoring is essential. Prior to commencing therapy, disclose any pre-existing cardiac, hepatic, or renal conditions, as well as all concurrent medications, as drug interactions are possible. This medication is contraindicated in pregnancy and lactation; effective contraception is mandatory for both partners during treatment.
Uses of Taxeleon 300mg Injection
Cancers of the breast, lung (non-small cell type), and pancreas.
Major Benefits of Taxeleon 300mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Taxeleon 300mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Taxeleon 300mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Taxeleon 300mg Injection works:
Taxeleon 300mg Injection is a chemotherapy agent that disrupts microtubule function, essential for cancer cell division and proliferation. This action inhibits cancer growth and leads to cell death.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Taxeleon 300mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Taxeleon 300mg Injection during pregnancy carries a confirmed risk to the fetus. Therefore, its use is contraindicated. In exceptional, life-threatening circumstances, a physician might consider prescribing it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Taxeleon 300mg Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
The injectable medication Taxeleon 300mg may induce adverse reactions that could impair driving ability. While driving between Taxeleon 300mg injection cycles isn't inherently prohibited, the medication's alcohol content suggests caution regarding driving.
KidneySAFE IF PRESCRIBED
Taxeleon 300mg Injection can be administered to patients with kidney disease without altering the dosage. Nevertheless, patients with pre-existing kidney conditions should consult their physician before use.
LiverCAUTION
Patients with hepatic impairment should receive Taxeleon 300mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Taxeleon 300mg Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Taxeleon 300mg Injection :
NA
Facts to Know About Taxeleon 300mg Injection
| Label | Value |
|---|---|
| Chemical Type | Taxane-Based Compounds |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Taxanes: Antimicrotubule Agents |
